Literature DB >> 3533996

Cancer chemotherapy: new strategies for success.

N A Berger.   

Abstract

Mesh：

Substances：

Year:  1986        PMID： 3533996      PMCID： PMC423794          DOI： 10.1172/JCI112692

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  83 in total

1.  Synergistic interaction of anticancer agents: a cellular perspective.

Authors:  F Valeriote; H s Lin
Journal:  Cancer Chemother Rep       Date:  1975 Sep-Oct

2.  Combination chemotherapy in the treatment of advanced Hodgkin's disease.

Authors:  V T Devita; A A Serpick; P P Carbone
Journal:  Ann Intern Med       Date:  1970-12       Impact factor: 25.391

3.  Salvage chemotherapy with ABVD in MOPP-resistant Hodgkin's disease.

Authors:  A Santoro; V Bonfante; G Bonadonna
Journal:  Ann Intern Med       Date:  1982-02       Impact factor: 25.391

4.  Long-term remission durability and functional status of patients treated for diffuse histiocytic lymphoma with the CHOP regimen.

Authors:  J O Armitage; M A Fyfe; J Lewis
Journal:  J Clin Oncol       Date:  1984-08       Impact factor: 44.544

5.  An in vitro characterization of interstrand cross-links in DNA exposed to the antitumor drug cis-dichlorodiammineplatinum(II).

Authors:  W A Deutsch; A L Spiering; G R Newkome
Journal:  Biochem Biophys Res Commun       Date:  1980-12-16       Impact factor: 3.575

6.  Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine).

Authors:  O W Griffith; A Meister
Journal:  J Biol Chem       Date:  1979-08-25       Impact factor: 5.157

7.  The increasing incidence of central nervous system leukemia in children. (Children's Cancer Study Group A).

Authors:  A E Evans; E S Gilbert; R Zandstra
Journal:  Cancer       Date:  1970-08       Impact factor: 6.860

8.  Recurrent childhood lymphocytic leukemia following cessation of therapy: treatment and response.

Authors:  G Rivera; C B Pratt; R J Aur; M Verzosa; H O Hustu
Journal:  Cancer       Date:  1976-04       Impact factor: 6.860

9.  Poly(ADP-ribose) Polymerase inhibitors preserve nicotinamide adenine dinucleotide and adenosine 5'-triphosphate pools in DNA-damaged cells: mechanism of stimulation of unscheduled DNA synthesis.

Authors:  J L Sims; S J Berger; N A Berger
Journal:  Biochemistry       Date:  1983-10-25       Impact factor: 3.162

10.  Synergistic antileukemic effect of 6-aminonicotinamide and 1,3-bis(2-chloroethyl)-1-nitrosourea on L1210 cells in vitro and in vivo.

Authors:  N A Berger; D M Catino; T J Vietti
Journal:  Cancer Res       Date:  1982-11       Impact factor: 12.701
View more
  6 in total

1.  Cytotoxic and antitumor effects of the norepinephrine analogue meta-iodo-benzylguanidine (MIBG).

Authors:  L A Smets; B Bout; J Wisse
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

2.  Magnetic Resonance Imaging and Spectroscopy: Application to Experimental Neuro-Oncology.

Authors:  Brian D Ross; Thomas L Chenevert; Boklye Kim; Oded Ben-Yoseph
Journal:  Q Magn Reson Biol Med       Date:  1994

3.  Oral buccoadhesive films of ondansetron: Development and evaluation.

Authors:  Rachna Kumria; Vishant Gupta; Sanjay Bansal; Jyoti Wadhwa; Anroop B Nair
Journal:  Int J Pharm Investig       Date:  2013-04

4.  Metoclopramide enhances the effect of cisplatin on xenografted squamous cell carcinoma of the head and neck.

Authors:  E Kjellén; J Wennerberg; R Pero
Journal:  Br J Cancer       Date:  1989-02       Impact factor: 7.640

5.  Oxidation therapy: the use of a reactive oxygen species-generating enzyme system for tumour treatment.

Authors:  O Ben-Yoseph; B D Ross
Journal:  Br J Cancer       Date:  1994-12       Impact factor: 7.640

6.  NIR and Reduction Dual-Sensitive Polymeric Prodrug Nanoparticles for Bioimaging and Combined Chemo-Phototherapy.

Authors:  Shuying Li; Yanjuan Wu; Xiukun Xue; Siyuan Liu
Journal:  Polymers (Basel)       Date:  2022-01-11       Impact factor: 4.329
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.